Title: Pyuria Associated Pyocolpos in the Neonates with Rare manifestations of Distal Vaginal Obstruction: Clinical, and Biomarkers Profiles in the Management Strategies
Author: Manal Mohammed Kadhim
DOI: https://dx.doi.org/10.18535/jmscr/v4i11.108
Abstract
Background: The diagnosis of distal vaginal atresia is rare in the neonate unless the hydromucocolpos was developed. Pyuria and pyometrocolpos may complicate hydromucocolpos, it may present with severe obstructive uropathy and septicemia.
Aim: to evaluate the role of combinations of clinical, microbial and immunological parameters in enhancing and to discuss the management strategies.
Patients and Methods: Twenty-eight patients presented to the pediatrics surgery ward with clinical signs of congenital distal vaginal obstruction were prospectively studied and compared with 20 healthy control group. The clinical records and radiological findings together with laboratory findings were reviewed. Urine sample collected for enzyme-linked immunosorbent assay to measure the urinary levels of interleukin IL-4, IL- 6, IL-8 and IL-10 and for macroscopically examination and culture.
Results: There was a significant rising in the immunological biomarkers in all patients group as compared with control group regardless they have associated anomalies or not, and significant correlation between IL-6, IL-8 and TNF-α rising scores with patients already presented with obstructive uropathies.
Conclusion: Pyuria associated pycolpos in congenital vaginal obstruction is a marker for underlining urinary tract abnormalities.This should rise management strategies with early picking up the pathology promoting optimal outcome.
Keyword: Pyuria, Pyocolpos. Obstrective uropatheies, Proi-mflammatory cytokine.
References
1. Gray SW et al. The female reproductive tract. In: Skandalakis JE, Gray SW, editors. Embryology for surgeons. Balti-more (MD): Williams & Wilkins; 1994; p.816-47.
2. Salvatore CA, Lodovicci O. Vaginal agenesis: an analysis of ninety cases. Acta Obstet Gynecol Scand 1978; 57:89-94.
3. Jones HW: Reconstruction of congenital uterovaginal anomalies. In: Rock JA, Murphy AA, Jones HW, eds. Female Reproductive Surgery. Baltimore, Md: Lippincott Williams & Wilkins; 1992; 246.
4. Banerjee AK et al. Sonographic detection of neonatal hydrometrocolpos. Br J Radiol 1992 Mar; 65(771): 268-71[Medline].
5. David A et al. Hydrometrocolpos and poly dactyly: a common neonatal presentation of Bardet-Biedl and McKusick-Kaufman syndromes.J Med Genet. 1999; 36:599–603. [PMC free article: PMC1762973] [PubMed: 10465109].
6. Riise R et al. Intra familial variation of the phenotype in Bardet-Biedl syndrome. Br J Ophthalmol. 1997 ;81 :37 8–85. [PMC free article: PMC1 7 221 98] [PubMed: 9227 203].
7. Harnett JD et al. The spectrum of renal disease in Laurence-Moon-Biedl syndrome Eng J Med 1988; 319:615-18.
8. McCann E et al. Genitourinary malformat-ions as a feature of the Pallister–Hall syndrome: Clinical Dysmorphology 2006; 15:75–79.
9. Imamoglu M et al: Two cases of pyometrocolpos due to distal vaginal atresia. PediatrSurgInt 2005 Mar; 21(3): 217-9[Medline] .
10. Dick PT, Feldman W. Routine diagnostic imaging for childhood urinary tract infections: a systematic overview. J Pediatr 1996; 128:15-22.
11. Bleves S., and G. R. Cornelis. How to survive in the host: The Yersinia lesson. Microbes Infect. 2000; 2:1451–1460.
12. Svanborg C et al. Cytokine responses during mucosal infections: role in disease pathogenesis and host defense. Curr. Opin. Microbiol.1999; 2:99–105.
13. Olszyna D et al. Sequential measurements of chemokines in urosepsis and experimental endotoxemia.J. Clin. Immunol.1999;19:399–405.
14. Otto G et al . Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection.J. Infect. Dis.1999; 179:172–179.
15. Haraoka M et al . Neutrophil recruitment and resistance to urinary tract infection.J Infect. Dis. 1999; 180:1220–1229.
16. Suranyi MG et al. Elevated levels of tumour necrosis factor-αα in the nephrotic syndrome in humans. American journal of kidney disease, 1993, 21(3):251–9.
17. Spencer R, Levy DM: Hydrometrocolpos. Ann Surg. 1962; 155:558- 571.
18. Rayband C et al. Mayer-Rokitansky-Kuster-Hauser Syndrome: associated pathologies. Arch Pediatr. 2001; 8:1209-13.
19. Meyer WR et al . Combined abdominal perineal sonography to assist in diagnosis of transverse vaginal septum. Obstet Gynecol. 1995; 85:882-884.
20. Brevetti LS et al. Pyocolpos: diagnosis and treatment. J Pediatr Surg. 1997; 32:110-1.
21. Srivastava P et al. Pyocolpos with distal vaginal atresia during infancy presented with acute intestinal obstruction and acute urinary retention: report of a rare case. Internet J Surg.2009 Aug.12; 2:17.
22. Jodal U and Hansson S: Urinary tract infection. In: Pediatric Nephrology. Edited by Holliday, M.A., Barratt, T.M., and Anver, E.D., Baltimore: Villiams& Wilkins, 1994; pp. 950–62
23. Downs SM. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999; 103: e54.
24. Williams DI, Kenawi MM. The prognosis of pelvi-ureteric obstruction in childhood: A review of 190 cases. Eur J Urol 1976; 2: 57–63.
25. Bauer SB, Retik AB. Bladder diverticula in infants and children. J Urol 1974; 3: 712–5.
26. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 Suppl 1A:5S-13S.
27. Mehmet D et al. URINARY AND SER-UM CYTOKINE LEVELS IN PATIENTS UNDERGOING SWL. September - October, 2001;27 (5): 495-499.
28. Lotz M et al. Interleukin-6 and interstitial cystitis. J Urol, 1994;152: 869-873.
29. Hang L et al. Cytokine repertoire of epithelial cells lining the human urinary tract. J Urol.1998; 159: 2185-2192.
30. Ohta K et al. Detection and clinical usefulness of urinary interleukin-6 in the disease of the kidney and the urinary tract. ClinNephrol.1992; 38: 185-189.
31. Wang J et al. Clinical significance of urinary interleukin-6 in children with reflux nephropathy. J Urol 2001; 165(1):210-214.
32. Sheu JN et al . Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine. 2006; 36:276-82.
33. Krzemien G et al. Urinary levels of interleukin-6 and interleukin-8 in children with urinary tract infections to age 2. Med Sci Monit. 2004;10:CR593-7.
34. Galanakis E et al. Urine interleukin-8 as a Marker of Vesicoureteral Reflux in Infa-nts. Pediatrics 2006;117(5): e863-e867.
35. Chaly Y et al. Differential action of human defensin HNP-1 on production of TNF-a, ILlb and IL-8 by human monocytes in vitro. Cytokine 1995; 7: 629 (A-207)
36. Tullus K et al. Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up. PediatrRadiol 1994; 24(7):513-515.
37. Tramma D . Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring. PediatrNephrol 2012; 27:1525-1530.
38. Tracey KJ et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986; 234: 470-474.
39. Ninan GK et al. Urinary cytokines as markers of reflux nephropathy J Urol,1999; 162: 1739-1742.
40. Nakazato Y et al. Interleukin-4 modulates collagen synthesis by human mesangial cells in a type-specific manner. Am. J. Physiol. 1996;270: F447–F453. [PubMed]
41. Sinuani I et al. Role of IL-10 in the progression of kidney disease World J Transplant. 2013 Dec 24;3(4):91-8
42. M. G.Madsen, “Urinary biomarkers in hydronephrosis,” Danish Medical Journal, vol. 60, no. 2, Article IDB4582, 2013.
43. Buckham TA et al. Evaluation of five interleukin genes for association with end-stage renal disease in white Europeans. Am J Nephrol. 2010, 32: 103-108.
44. Balakrishnan VS et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, function-ality, and serum albumin. Kidney Int. 2004; 65: 1449-1460.
45. Carrero JJ et al. Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: a dreadful triad. Semin Dial. 2009; 22: 381-386.
46. Silverstein DM: Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2009; 24: 1445-1452.